Didier Colau
Publications by Year
Research Areas
Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Cell Function and Interaction, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase(2003)2,279 cited
- → Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase(2012)566 cited
- → Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor(2000)358 cited
- → Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22(2001)249 cited
- → Membrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg(2009)245 cited
- → A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by geneMAGE-3(2001)220 cited
- → Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes(2017)217 cited
- → Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules(2010)212 cited
- A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.(2002)
- → Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes(2008)186 cited